Probability of elimination in relation to the Ov16 antibody prevalence as measured one year after the last treatment, in relation to test characteristics, for scenarios with treatment coverage of 65%.
<p>In the figures on the left, sensitivity is varied while specificity is fixed at 99%. In the figures on the right, the sensitivity is fixed at 80%, while specificity is varied. Note that the horizontal axis is ordered from highest to lowest. The lines connect outcomes for different treatment durations with otherwise the same assumptions. The Ov16 antibody prevalence was estimated according to hypothesis 2 in 0–9 year old children.</p
